Aldeyra Therapeutics to Participate in Fireside Chat at the SVB Securities Global Biopharma Conference
09 February 2023 - 11:00PM
Business Wire
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a
clinical-stage biotechnology company developing innovative
therapies for the treatment of immune-mediated diseases, today
announced that Todd C. Brady, M.D., Ph.D., President and Chief
Executive Officer, will participate in a fireside chat at the SVB
Securities Global Biopharma Conference. The conference is being
conducted in a virtual format February 14-16, 2023.
Dr. Brady’s conversation with Marc Goodman, Senior Research
Analyst at SVB Securities, is scheduled to begin at 10:00 a.m. ET
Thursday, February 16, 2023. To view the live webcast, log in to
the Investors & Media section of the Aldeyra website at
https://ir.aldeyra.com. Following the fireside chat, the webcast
will be archived for 90 days.
About Aldeyra
Aldeyra Therapeutics is a clinical-stage biotechnology company
developing innovative therapies designed to treat immune-mediated
diseases. Our approach is to discover pharmaceuticals that modulate
immunological systems, instead of directly inhibiting or activating
single protein targets, with the goal of optimizing multiple
pathways at once while minimizing toxicity. Our pre-commercial
product candidates are reproxalap, a potential treatment for dry
eye disease and allergic conjunctivitis, and ADX-2191, a potential
treatment for primary vitreoretinal lymphoma, proliferative
vitreoretinopathy, and retinitis pigmentosa. In addition, we are
developing other product candidates, including ADX-629 and
chemically related molecules, for the potential treatment of
systemic and retinal immune-mediated diseases. For more
information, visit https://www.aldeyra.com/ and follow us on
LinkedIn, Facebook, and Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230208005570/en/
Investor & Media Contact: Scott Solomon Sharon
Merrill Associates, Inc. Tel: (857) 383-2409
ALDX@investorrelations.com
Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
From Apr 2023 to Apr 2024